Peripheral Artery Occlusion: Treatment with Abciximab plus Urokinase versus with Urokinase Alone— A Randomized Pilot Trial (the PROMPT Study)

Abstract

In patients with lower extremity arterial occlusion who were undergoing urokinase thrombolysis, adjunctive abciximab treatment resulted in faster thrombus dissolution and improved amputation-free survival, despite an increase in major bleeding.